Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00187577 · ClinicalTrials.gov registry record · NA
Efficacy Study of Latanoprost and Bimatoprost Solutions in Promoting Eyelash Growth in Patients With Alopecia Areata
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT00187577 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 14 participants.
The verdict
NCT00187577, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
This is a single center, randomized, investigator-masked study to determine the efficacy and safety of latanoprost and bimatoprost ophthalmic solutions in promoting eyelash growth in patients who have lost their eyelashes due to alopecia areata. These medications are FDA-approved as eyedrops for patients with glaucoma who have been noted to grow longer, darker, and thicker eyelashes with their use. In this study, patients will be asked to apply these solutions to the affected eyelid margins of one eye with a sterile cotton-tipped applicator once a day.
Interventions
- DRUG Latanoprost (Xalatan)
- DRUG Bimatoprost (Lumigan)
- DRUG Topical application of latanoprost solution to eyelid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2005-06 |
| Est. Completion | 2006-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00187577
The ClinicalTrials.gov registry entry for NCT00187577 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Latanoprost (Xalatan) is the first listed.
NCT00187577 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00187577 about?
NCT00187577 is a clinical study titled "Efficacy Study of Latanoprost and Bimatoprost Solutions in Promoting Eyelash Growth in Patients With Alopecia Areata". This is a single center, randomized, investigator-masked study to determine the efficacy and safety of latanoprost and bimatoprost ophthalmic solutions in promoting eyelash growth in patients who have lost their eyelashes due to alopecia areata. These medications are FDA-approved as eyedrops for pat...
What is the current status of trial NCT00187577?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2005-06. Estimated completion is 2006-03.
What interventions are being tested in trial NCT00187577?
The interventions under investigation include: Latanoprost (Xalatan) (DRUG), Bimatoprost (Lumigan) (DRUG), Topical application of latanoprost solution to eyelid (DRUG).
Who is sponsoring clinical trial NCT00187577?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.